Today’s AI Top Pick: BILI

8/12/2026 · Recently Alerted Turnaround screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Measured daily model accuracy · BILI76%363 resolved forecasts · 45d window · verify →

Today's pick · Recently Alerted TurnaroundBILIBUY NOW8.6 / 108/12/2026

BILI is the cleanest multi-timeframe setup in the pool with no landmine headlines. Every forecast horizon points up: 4h fc_short +31.68% / fc_mid +47.32% / fc_long +53.64%, 1d fc_short +24.64% / fc_mid +42.84% / fc_long +36.15%, and even 1wk goes fc_short +4.12% / fc_long +20.62%. That is genuine multi-TF agreement — nearly every other candidate in this pool has at least one horizon flipping negative (APP -43.9% weekly, VST -60% weekly, AMSC -49% weekly, NRG -28.8% weekly, TMUS negative across weekly). Entry quality is excellent. Position in 21-bar range is 37.4% (4h), 28.8% (1d), 14.8% (1wk) — mid-to-lower, not chasing a rip. Drawdown from 21-bar highs is only -6.5% to -29.4%, so we get a discount without a broken trend. Kronos bullish_prob is 1.0 and near_term_bullish is 1.0 — the tape agrees with the screen. Fundamentals confirm: PEG 0.52, fwdPe 13.47, EPS next Y +27.1%, sales YoY +11.2%, recom 1.32 (strong buy), targetUpsidePct +59.5%, ROE 9.35%, debt/eq 0.61 — reasonable, growth-at-a-price, not stretched. Fundamental_score is 8/8. Perf 1Y is -22.2%, matching the turnaround thesis without the extreme -50%+ scars that make names like APP or WING harder to trust. The kicker is the news: BILI has no negative catalyst — the only relevant headlines are 'Undervalued Or Recent Bounce Already Priced In?' and neutral ADR trading updates. Compare to landmines everywhere else — ONON down 17.8% on lowered guidance (yesterday), APP BofA downgrade + growth concerns, OPFI multiple analyst cuts on weak Q2, SRAD cut 2026 outlook + UBS downgrade, FUTU DOJ probe overhang, MNDY Wolfe downgrade. BILI is the highest-quality forecast in the pool that is not fighting a fresh negative headline. TODAY is the right entry because the daily/4h forecast surge (+24-31% short-horizon) suggests the move is imminent and the weekly still shows -29% dd from high — you're not late.

Entry zone

$17.40-$17.90 (current $17.76, add on any dip toward the 4h/1d support cluster near $17.20)

Stop loss

$15.65 (below the recent 1wk drawdown floor, ~-12% risk)

First target

$21.00 (+18%, aligns with 4h fc_short and 1d fc_short zone)

Longer target

$25.50-$27.00 (+43-52%, aligns with 4h fc_long +53.6% and 1d fc_long +36%)

Risks

China ADR political/regulatory tail risk — any adverse HK/US listing headline can gap the stock 5-10% independent of fundamentals
Weekly recent_21bar_pct is -20.47% and dd_from_21bar_high is -29.39% — still in a broader downtrend that needs to be reclaimed
Operating margin only 4.13% and profit margin 4.58% — the +27% EPS growth is coming off a low base, execution risk is real
Sales YoY of just 11.2% is the weakest growth print in the top-tier peer set (APP 28.5%, ONON 29.3%, ALNY 95%) — the growth-story premium is thinner
Short float 5.88% is modest but a broad China-tech tape sell-off could still trigger a fast -8-10% flush

Honorable mentions

ALNYHighest expected_return_pct (64.6%), monster forecasts (4h fc_long +73%, 1d +57%), ROE 100.7%, sales +95% YoY, pos_in_range 4-19% (deeply oversold). Only reason it's not #1: 1wk fc_short/mid/long all slightly negative (-9.8/-4.0/-3.2) and 'drugs that missed the mark' headline is a mild overhang.

INTR4h fc_long +72.7%, 1d fc_long +42.4%, 1wk fc_long +9% — rare full-TF alignment. PEG 0.22, fwdPe 5.26, sales +51% YoY, ROE 15.5%. Record Q2 profitability headline is a positive catalyst. Slightly weaker recom (1.83) and Brazil-ADR risk hold it back from #1.

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	BILI	BUY NOW	8.6	Full multi-TF forecast alignment, mid-range entry, PEG 0.52, no negative headlines — cleanest setup in the pool.
2	ALNY	BUY NOW	8.3	Deep oversold biotech with +73% 4h long forecast and 95% sales growth; weekly forecast slightly negative is the only blemish.
3	INTR	BUY NOW	8.1	Full-TF positive forecasts, PEG 0.22, record Q2 profitability catalyst, +75% analyst upside.
4	FICO	BUY NOW	7.6	Extreme oversold (pos_in_range <1% on 1d), 4h/1d forecasts +36-40%, elite margins (52% oper, 34% profit).
5	WMG	BUY NOW	7.3	All 4 TFs positive forecasts, pos_in_range 0-12%, strong Q3 earnings just posted — quiet compounder.
6	TIGR	BUY NOW	7.2	Massive forecasts (+70% across horizons), PEG-free but PE 7.9, near_term 1.0; slight downgrade recent.
7	MLCO	BUY NOW	7.0	All-TF positive, 1d fc_long +30.7% / 1wk +44%, forward PE 8.15, quiet accumulation setup.
8	ONON	BUY PULLBACK	6.9	Full 4-TF alignment and oversold, but yesterday's -17.8% guidance reaction needs to settle before adding.
9	BIRK	BUY NOW	6.7	Full 4-TF positive, moderate magnitudes, decent fundamentals; board exit is a minor overhang.
10	CALX	BUY NOW	6.5	4h at top of range (100%) but 1wk oversold at 26%, recom 1.25, PEG 0.48; entry is slightly extended intraday.
11	APP	BUY PULLBACK	6.2	Huge 4h/1d bounce forecast (+54-74%) but 1wk fc_long -43.9% and BofA downgrade — trade it, don't marry it.
12	OPFI	BUY PULLBACK	6.0	Cheap (fwdPe 3.33) with big 4h/1d forecasts but multiple analyst cuts on weak Q2 just landed.
13	PSIX	WAIT	5.9	1d at 100% of range and RSI 64.85 — extended; 1wk forecast is -63% long. Chase risk.
14	PFSI	BUY NOW	5.8	Full-TF bullish, near_term 1.0, EPS next Y +102%, but recom 2.0 is weakest in class and targets recently cut.
15	KVYO	BUY PULLBACK	5.6	4h at 95% range and PE 866 — wait for pullback; long-horizon forecasts +38% are attractive.
16	MIR	BUY PULLBACK	5.5	Solid 4h/1d bounce forecasts but 1wk fc_long -14.75% and PE 173 — quality bounce trade only.
17	JBI	BUY NOW	5.4	1wk fc_long +116% is huge, all TFs positive, but small cap and lower conviction fundamentals.
18	SRAD	WAIT	5.2	Big short-term bounce forecasts undermined by UBS downgrade and cut 2026 outlook — falling knife.
19	TMUS	WAIT	5.1	Mega-cap defensive but 1wk forecasts all negative and 'earnings loser with more downside ahead' headline.
20	ETOR	BUY PULLBACK	5.0	Deep oversold, +86.7% target upside, but missing bullish_prob signal and only 2 TFs available.
21	RBBN	BUY PULLBACK	4.9	All-TF forecasts positive and recom 1.0, but sales -7.6% YoY and micro-cap illiquidity risk.
22	ORCL	WAIT	4.6	4h/1wk forecasts negative and layoff headlines — screen passes but tape is deteriorating.
23	FUTU	WAIT	4.5	Strong short/mid forecasts undercut by 1wk -20.7% mid forecast and DOJ probe/class-action overhang.
24	MNDY	WAIT	4.3	1d/1wk forecasts great but 1h/4h negative, Wolfe downgrade, near_term_bullish only 0.2.
25	NRG	AVOID	4.1	1wk fc_long -28.8% and 'shares crashing' headline — screen pass but trend is broken.
26	VST	AVOID	3.8	1wk fc_long -60% and sales -20.55% YoY — deteriorating trend despite good fundamentals.
27	AMSC	AVOID	3.5	1wk fc_long -48.9% and dd -40.9% — momentum is dead, screen pass is misleading.
28	WING	AVOID	3.4	Perf 1Y -66% with 'growth story losing steam' headline — knife-catcher setup even with big forecasts.
29	SDA	AVOID	2.8	Micro-cap ($82M), PE 445, extreme forecast outliers (+765% 1wk long) — untradeable speculation.
30	BESS	AVOID	2.5	$25M market cap, no revenue/margin data, ROE -30.7% — pure gamble regardless of screen match.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord